Preconception care: Preliminary estimates of costs and effects of smoking cessation and folic acid supplementation

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 5, 2004, Pages 338-344

  De Weerd, Sabina ^b   Polder, Johan J ^b   Cohen Overbeek, Titia E ^b   Zimmermann, Luc J I ^b   Steegers, Eric A P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Birth defects; Birth weight; Folic acid; Preconception care; Smoking cessation

Indexed keywords

FOLIC ACID;

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; LOW BIRTH WEIGHT; MATERNAL CARE; NETHERLANDS; NEURAL TUBE DEFECT; OUTCOMES RESEARCH; PATIENT COUNSELING; PERINATAL DEATH; PREGNANCY; PRIORITY JOURNAL; SMOKING CESSATION; VERY LOW BIRTH WEIGHT; VITAMIN SUPPLEMENTATION;

ADULT; COST SAVINGS; COST-BENEFIT ANALYSIS; COUNSELING; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HOSPITAL COSTS; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MORBIDITY; NETHERLANDS; NEURAL TUBE DEFECTS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY OUTCOME; SMOKING CESSATION;

EID: 2442685477     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Waitzman NJ, Romano PS, Scheffler RM: Estimates of the economic costs of birth defects. Inquiry 1994;31:188-205
2. Halsey CL, Collin MF, Anderson CL: Extremely low birth weight children and their peers: A comparison of preschool performance. Pediatrics 1993;91:807-811
3. Allaire AD, Cefalo RC: Preconceptional health care model. Eur J Obstet Gynecol Reprod Biol 1998;78:163-168
4. American College of Obstetricians and Gynecologists: Preconceptional care. Int J Gynecol Obstet 1995;50:201-207
5. Scheffler RM, Feuchtbaum LB, Phibbs CS: Prevention: The cost-effectiveness of the California diabetes and pregnancy program. Am J Public Health 1992;82:168-175
6. Elixhauser A, Weschler JM, Kitzmiller JL, et al: Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993;16:1146-1157
7. Elixhauser A, Kitzmiller JL, Weschler JM: Short-term cost benefit of pre-conception care for diabetes. Diabetes Care 1996;19:384
8. Herman WH, Janz NK, Becker MP, et al: Diabetes and pregnancy: Preconception care, pregnancy outcomes, resource utilization and costs. J Reprod Med 1999;44:33-38
9. Wildhagen MF, van Os TAM, Polder JJ, et al: Explorative study of costs, effects and savings of screening for female fragile X premutation and the full mutation carriers in the general population. Community Genet 1998;1:36-47
10. Verheij JBMG, Wildhagen MF, Hofstra RMW, et al: Preconceptional screening of couples for carriers of cystic fibrosis: A prospective evaluation of effects, costs and savings for different mutation detection methods. Community Genet 1999;2:74-81
11. College Tarieven Gezondheidszorg 2002. http://www.ctg-zorg.nl
12. Central Bureau for Statistics: Geboorte: Kerncijfers. Voorburg/Heerlen, the Netherlands 2002. http://statline.cbs.nl
13. Wilcox AJ, Baird DD, Weinberg CR: Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999;340:1796-1799
14. Rasch V, Knudsen LB, Wielandt H: Pregnancy planning and acceptance among Danish pregnant women. Acta Obstet Gynecol Scand 2001;80:1030-1035
15. Hille E, de Kroon M: Epidemiology of Infertility. iMTA/iMGZ, Erasmus University Rotterdam, Rotterdam, the Netherlands (in Dutch) 1992
16. Czeizel AE, Dudas I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835
17. Berry RJ, Li Z, Erickson JD, et al: Prevention of neural-tube defects with folic acid in China: China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-1490
18. Werler MM, Shapiro S, Mitchell AA: Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-1261
19. Reefhuis J, Samren EB, van Diem MT, et al: Tables 1981-1998. EUROCAT Registration of Congenital Abnormalities, Northern Netherlands and Southwestern Netherlands. Groningen, the Netherlands, Department of Medical Genetics, Medical Faculty, University of Groningen, 2000
20. De Weerd S, Thomas CMG, Cikot RJLM, et al: Preconception counseling improves folate status of women planning pregnancy. Obstet Gynecol 2002;99:45-50
21. Pollack HP, Lantz PM, Frohna JG: Maternal smoking and adverse birth outcomes among singletons and twins. Am J Public Health 2000;90:395-400
22. Floyd RL, Rimer BK, Giovino GA, et al: Review of smoking in pregnancy: Effects on pregnancy outcomes and cessation efforts. Annu Rev Public Health 1993;14:379-411
23. Pollack HA: Sudden infant death syndrome, maternal smoking during pregnancy, and the cost-effectiveness of smoking cessation intervention. Am J Public Health 2001;91:432-436
24. Marks JS, Koplan JP, Hogue CJ, et al: A cost-benefit analysis of smoking cessation for pregnant women. Am J Prev Med 1990;6:282-289
25. Dutch Association for Obstetrics and Gynecology: National Perinatal Database secondary care (LVR2): Annual report 2000. Utrecht, the Netherlands, DAOG, 2000
26. Dutch Association for Pediatricians: National Neonatal Database (LNR): Annual report 2000. Utrecht, the Netherlands, DAP, 2000
27. Oostenbrink J, Koopmanschap MA, Rutten FFH: Manual for Cost Analysis. Amstelveen, the Netherlands, iMTA/College Voor Zorgverzekeringen, 2000 (in Dutch)
28. Kelly AE, Haddix AC, Scanlon KS, et al: Cost-effectiveness of strategies to prevent neural tube defects. In Cost-Effectiveness in Health and Medicine. Edited by Gold MR, Siegel JE, Russel LB, et al. New York, Oxford University Press, 1996, pp 313-348
29. Takken J, Polder JJ, Meerding WJ, et al: Costs of Diseases in the Netherlands. Bilthoven, the Netherlands, National Institute of Public Health and the Environment, 2002. http: //www.kostenvanziekten.nl
30. Itikala PR, Watkins ML, Mulinare J, et al: Maternal multivitamin use and orofacial clefts in the offspring. Teratology 2001;63:79-86
31. Botto LD, Mulinare J, Erickson JD: Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 2000;151:878-884
32. Botto LD, Mulinare J, Erickson JD: Occurrence of omphalocele in relation to maternal multivitamin use: A population-based study. Pediatrics 2002;109:904-908
33. Hack MH, Flannery DJ, Schluchter M, et al: Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002;346:149-157
34. Gaytant MA, Cikot RJ, Braspenning JC, et al: Preconception counseling in family practice: A survey of 100 family physicians. Ned Tijdschr Geneeskd 1998;142:1206-1210
35. De Weerd S, van der Bij AK, Cikot RJLM, et al: Preconception care: A screening tool for health assessment and risk detection. Prev Med 2002;34:505-511
36. De Weerd S, van der Bij AK, Braspenning JCC, et al: Psychological impact of preconception counseling: Assessment of anxiety before and during pregnancy. Community Genet 2001;4:129-133
37. Adams MM, Bruce FC, Shulman HB, et al: Pregnancy planning and pre-conception counseling: The PRAMS Working Group. Obstet Gynecol 1993;82:955-959